EFFICACY OF THROMBOLYTIC THERAPY WITH STREPTOKINASE USING A NEW ADMINISTRATION SCHEME.
D000792:Angiography; D001011:Aorta; D001012:Aorta, Abdominal; D002561:Cerebrovascular Disorders; D003850:Deoxyribonuclease I; D005853:Geriatrics; D006333:Heart Failure; D007275:Injections, Intravenous; D007383:Intermittent Claudication; D008875:Middle Aged; D010958:Plasminogen; D011379:Prognosis; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D013923:Thromboembolism; D015912:Thrombolytic Therapy; D014116:Toxicology
D010958:Plasminogen; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase
ANGIOGRAPHY; AORTA, ABDOMINAL; CEREBROVASCULAR DISORDERS; GERIATRICS; HEART FAILURE, CONGESTIVE; INJECTIONS, INTRAVENOUS; INTERMITTENT CLAUDICATION; MIDDLE AGE; PLASMINOGEN; PROGNOSIS; STREPTODORNASE AND STREPTOKINASE; THROMBOEMBOLISM; TOXICOLOGIC REPORT